The following represents disclosure information provided by authors of this abstract. The ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer Planning Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Disruption of protocadherin function and correlation with metastasis and cancer progression in TCGA patients.
James Shima
Employment or Leadership Position - NextBio
Stock Ownership - NextBio
Joseph Delaney
Employment or Leadership Position - NextBio
Stock Ownership - NextBio
Anita Umesh
Employment or Leadership Position - NextBio
Stock Ownership - NextBio
Jenny Park
Employment or Leadership Position - NextBio
Stock Ownership - NextBio
Gregory Wall
Employment or Leadership Position - NextBio
Stock Ownership - NextBio
Qiaojuan Su
Employment or Leadership Position - NextBio
Stock Ownership - NextBio
Mamatha Shekar
Employment or Leadership Position - NextBio
Stock Ownership - NextBio
Ilya Kupershmidt
Employment or Leadership Position - NextBio (B)
Stock Ownership - NextBio (B)